Close

OREX Financial Facts

Interest income: 239K
Interest expense: -1.99M
See Full Income Statement

Deferred revenue, less current portion: 6.36M
Total assets: 355.81M
See Full Balance Sheet

Orexigen Therapeutics (OREX) Earnings

  |   Expand Research on OREX
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +31.4% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -22.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/13/17 Q317 -$1.35-$2.13 +$0.78$18.9M$24.2M = Details
8/8/17 Q217 -$2.00N/A N/A $23.4M$19.14M = Details
5/9/17 Q117 -$4.67N/A N/A $19.1M$20M = Details
3/28/17 Q416 -$1.69-$1.18 -$0.51$13.88M$13.95M N/A Details
11/3/16 Q316 $1.12-$2.24 +$3.36$7M$8.17M N/A Details
8/4/16 Q216 -$1.73-$1.47 -$0.26$7.8M$6.88M N/A Details
5/4/16 Q116 -$0.15-$0.17 +$0.02$5M$8.26M N/A Details
2/26/16 Q415 -$0.12-$0.08 -$0.04$4.9M$14.07M N/A Details